Skip to main content
Clinical Trials/ACTRN12614001234606
ACTRN12614001234606CompletedPhase 4

Assessing the potential for silver dressings to enhance healing of diabetes-related foot ulcers.

The Royal Melbourne Hospital0 sites176 target enrollmentStarted: November 25, 2014Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
176

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Participants will need to have a confirmed diagnosis of diabetes and an ulcer distal to the level of the ankle. The ulcer will be of less than 6 weeks duration at the time of recruitment and participants will be 18 years or older.

Exclusion Criteria

  • Individuals who are pregnant, who have an allergy to silver, Mepilex or Zetuvit, wounds with tendons or underlying osteomyelitis and individuals with a life expectancy of less than 12 weeks will be excluded from the study.

Investigators

Similar Trials